These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19487982)

  • 1. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients.
    Hayakawa M; Katabami K; Wada T; Sugano M; Hoshino H; Sawamura A; Gando S
    Shock; 2010 Jan; 33(1):14-8. PubMed ID: 19487982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
    Sahebnasagh A; Saghafi F; Safdari M; Khataminia M; Sadremomtaz A; Talaei Z; Rezai Ghaleno H; Bagheri M; Habtemariam S; Avan R
    J Clin Pharm Ther; 2020 Dec; 45(6):1515-1519. PubMed ID: 32860252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
    Miyoshi S; Ito R; Katayama H; Dote K; Aibiki M; Hamada H; Okura T; Higaki J
    Drug Des Devel Ther; 2014; 8():1211-9. PubMed ID: 25214765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy.
    Lv H; Huang L; Yang X; Zhang C; Yu H; Shang X
    J Cardiothorac Surg; 2024 Jun; 19(1):399. PubMed ID: 38937755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery.
    Togo S; Matsuo K; Ishibe A; Nagano Y; Takahashi M; Mochizuki H; Osada S; Kameda K; Shimada H
    Hepatogastroenterology; 2008; 55(84):967-73. PubMed ID: 18705309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of the effects of ONO-5046 in patients with acute respiratory distress syndrome.
    Kadoi Y; Hinohara H; Kunimoto F; Saito S; Goto F; Kosaka T; Ieta K
    Anesth Analg; 2004 Sep; 99(3):872-877. PubMed ID: 15333424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis.
    Tsuboko Y; Takeda S; Mii S; Nakazato K; Tanaka K; Uchida E; Sakamoto A
    Drug Des Devel Ther; 2012; 6():273-8. PubMed ID: 23091371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome: a retrospective cohort study.
    Gao X; Zhang R; Lei Z; Guo X; Yang Y; Tian J; Huang L
    Ann Palliat Med; 2021 Nov; 10(11):11910-11917. PubMed ID: 34872315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis.
    Miyoshi S; Hamada H; Ito R; Katayama H; Irifune K; Suwaki T; Nakanishi N; Kanematsu T; Dote K; Aibiki M; Okura T; Higaki J
    Drug Des Devel Ther; 2013; 7():305-16. PubMed ID: 23596346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of a neutrophil elastase inhibitor, sivelestat, in patients with acute respiratory distress syndrome.
    Okayama N; Kakihana Y; Setoguchi D; Imabayashi T; Omae T; Matsunaga A; Kanmura Y
    J Anesth; 2006; 20(1):6-10. PubMed ID: 16421669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presepsin Values Predict Septic Acute Kidney Injury, Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation, and Shock.
    Shimoyama Y; Umegaki O; Kadono N; Minami T
    Shock; 2021 Apr; 55(4):501-506. PubMed ID: 32925599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy.
    Nagai Y; Watanabe M; Baba Y; Iwatsuki M; Hirashima K; Karashima R; Kurashige J; Kinoshita K; Baba H
    Surg Today; 2013 Apr; 43(4):361-6. PubMed ID: 23412514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
    Pu S; Wang D; Liu D; Zhao Y; Qi D; He J; Zhou G
    BMC Pulm Med; 2017 Nov; 17(1):148. PubMed ID: 29162066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.
    Xu J; Zhang C; Wu K; Qian Y; Hu W
    BMC Pulm Med; 2024 Jun; 24(1):283. PubMed ID: 38886709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of early sivelestat administration on acute lung injury and acute respiratory distress syndrome.
    Kido T; Muramatsu K; Yatera K; Asakawa T; Otsubo H; Kubo T; Fujino Y; Matsuda S; Mayumi T; Mukae H
    Respirology; 2017 May; 22(4):708-713. PubMed ID: 27990710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sivelestat on bronchial inflammatory responses after esophagectomy.
    Yamaguchi K; Sugasawa Y; Takeuchi K; Kugimiya T; Kumakura S; Iwanuma Y; Kajiyama Y; Tsurumaru M; Nagaoka I; Inada E
    Int J Mol Med; 2011 Aug; 28(2):187-92. PubMed ID: 21567070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic sivelestat for esophagectomy and in-hospital mortality: a propensity score-matched analysis of claims database.
    Takeda C; Takeuchi M; Kawasaki Y; Yonekura H; Nahara I; Kuwauchi A; Yoshida S; Tanaka S; Kawakami K
    J Anesth; 2019 Apr; 33(2):230-237. PubMed ID: 30612210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sivelestat sodium hydrate on severe respiratory failure after thoracic aortic surgery with deep hypothermia.
    Morimoto K; Nishimura K; Miyasaka S; Maeta H; Taniguchi I
    Ann Thorac Cardiovasc Surg; 2011; 17(4):369-75. PubMed ID: 21881324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients.
    Hoshi K; Kurosawa S; Kato M; Andoh K; Satoh D; Kaise A
    Tohoku J Exp Med; 2005 Oct; 207(2):143-8. PubMed ID: 16141683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effects of neutrophil elastase inhibitor on gastrointestinal dysfunction in sepsis.
    Sun JK; Li JJ; Deng YH; Yin X; Huangfu XT; Ye ZY; Zhou XH; Chen YM; Yuan ST; Wang X
    Clin Transl Sci; 2024 May; 17(5):e13829. PubMed ID: 38769746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.